Is Wall Street Bullish or Bearish on Cooper Companies Stock?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 28 2024
0mins
Should l Buy COO?
Source: NASDAQ.COM
Company Overview: The Cooper Companies, Inc., a leading medical device firm based in California, specializes in contact lenses and surgical products, with a market cap of $20.6 billion; however, its stock has underperformed compared to the broader market over the past year.
Stock Performance and Analyst Ratings: Following strong Q3 earnings that exceeded expectations, COO's stock rose 11.8%, and analysts maintain a consensus rating of "Strong Buy," with a mean price target suggesting potential upside from current levels.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy COO?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on COO
Wall Street analysts forecast COO stock price to rise
12 Analyst Rating
7 Buy
4 Hold
1 Sell
Moderate Buy
Current: 80.200
Low
73.00
Averages
90.33
High
100.00
Current: 80.200
Low
73.00
Averages
90.33
High
100.00
About COO
The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Strong Financial Performance: The Cooper Companies reported consolidated revenues of $1.024 billion for Q1 2026, reflecting a 6.2% year-over-year increase, with CooperVision revenue at $695 million, up 7.6%, indicating robust market performance and profitability.
- Free Cash Flow Growth: The company achieved $159 million in free cash flow during Q1, showcasing successful operational efficiency and capital allocation, leading management to raise the 2026 free cash flow guidance to $600 million to $625 million, demonstrating confidence in future growth.
- Progress on Strategic Priorities: CEO Albert White emphasized significant advancements in market share, operational excellence, and disciplined capital allocation, particularly in product launches and adoption in EMEA and Japan, highlighting the company's competitive edge in global markets.
- Optimistic Future Outlook: Management anticipates consolidated revenues of approximately $4.3 billion to $4.35 billion for fiscal 2026, reflecting organic growth of 4.5% to 5.5%, indicating that strategic investments and innovation will drive long-term growth.
See More

- Scientific Research Showcase: CooperVision will present multiple scientific papers at the 2026 Netherlands Contact Lens Congress, emphasizing how evidence-based care and continuous innovation support clear and comfortable contact lens wear across all ages, which is expected to enhance industry understanding of lens adaptability.
- Adaptation Study Findings: A study indicates that young adults report comparable vision quality and comfort within six months of using the MiSight® 1-day dual-focus design, underscoring the importance of managing patient expectations during the adaptation period, potentially increasing patient satisfaction.
- Multifocal Lens Research: CooperVision-supported research highlights satisfaction rates among multifocal lens wearers, particularly the opportunity for more proactive fitting of early presbyopic patients, suggesting that aligning closer with fitting guide recommendations could yield better outcomes.
- Industry Impact: The biennial Netherlands Contact Lens Congress attracts thousands of eye care professionals from around the globe, and CooperVision's participation not only showcases its leadership in the contact lens sector but may also drive broader acceptance of new technologies and fitting methods within the industry.
See More
- Market Decline: The S&P 500 index fell by 0.95%, the Dow Jones Industrial Average by 1.00%, and the Nasdaq 100 by 0.76%, reflecting market concerns that the ongoing Middle East war could drive energy prices higher, leading to inflation.
- Weak Employment Data: U.S. nonfarm payrolls unexpectedly dropped by 92,000 in February, with the unemployment rate rising to 4.4%, indicating a deteriorating labor market and exacerbating fears of an economic slowdown.
- Surge in Energy Prices: WTI crude oil prices surged over 9% to a 2.25-year high due to the ongoing conflict in the Middle East, raising inflation expectations and diminishing investor confidence in the stock market.
- Corporate Earnings Performance: Despite the overall market weakness, 73% of S&P 500 companies exceeded earnings expectations, with Q4 earnings projected to grow by 8.4%, demonstrating resilience among some firms that may provide future market support.
See More
- Bank Stocks Decline: All 101 stocks in the State Street SPDR S&P Bank ETF (KBE) fell on Friday as the spread between the 2- and 10-year Treasury yields widened, with Western Alliance Bancorp down nearly 12%, indicating rising future inflation expectations that could compress banks' net interest margins and increase credit risk.
- Fertilizer Stocks Rally: Fertilizer stocks surged again due to tight supplies from the Iran conflict, with CF Industries climbing 5% to a new 52-week high and a week-to-date gain of about 17%, reflecting strong market expectations for fertilizer demand amid geopolitical tensions.
- Airline Stocks Under Pressure: United Airlines shares tumbled nearly 4% after CEO Scott Kirby warned that rising fuel prices would have a
See More
- Market Decline: The S&P 500 index fell by 1.68%, with the Dow Jones Industrial Average hitting a 3.5-month low, reflecting market concerns that the Middle East war could drive energy prices higher, leading to inflation risks.
- Weak Labor Market: U.S. nonfarm payrolls unexpectedly dropped by 92,000 in February, with the unemployment rate rising to 4.4%, indicating a labor market health below expectations, which could slow consumer spending and impact economic growth.
- Surging Energy Prices: Amid escalating tensions in the Middle East, WTI crude prices surged over 7% to a 2.25-year high, likely pushing global fuel prices higher, which could affect airline profits and consumer spending.
- Optimistic Corporate Earnings: Despite market volatility, over 90% of S&P 500 companies have reported earnings, with 73% exceeding expectations, indicating strong corporate profitability, and S&P 500 earnings growth is projected to reach 8.4% for Q4.
See More
- Earnings Beat: Cooper Companies reported Q1 earnings of $1.10 per share, exceeding the analyst consensus of $1.03, indicating strong operational performance despite slight sales shortfall.
- Sales Miss: The company reported quarterly sales of $1.024 billion, slightly below the expected $1.026 billion, highlighting competitive pressures in certain market segments.
- Guidance Raised: Cooper Companies raised its FY2026 adjusted EPS guidance from $4.45-$4.60 to $4.58-$4.66, and increased sales guidance from $4.299 billion-$4.338 billion to $4.306 billion-$4.346 billion, reflecting management's confidence in future performance.
- Analyst Rating Changes: Following the earnings announcement, Needham analyst raised the price target from $99 to $101, Barclays from $98 to $103, while Citigroup lowered its target from $88 to $87, indicating varied market perspectives on Cooper Companies' outlook.
See More










